...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data.
【24h】

Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data.

机译:如PRISCUS清单所示,在德国老年人中开处方可能不适当的药物(PIM)。基于区域索赔数据的分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to estimate the prevalence of potentially inappropriate medication (PIM) in the elderly as indicated by Germany's recently published list (PRISCUS) and to assess factors independently associated with PIM prescribing, both overall and separately for therapeutic groups.Claims data analysis (Health Insurance Sample AOK Hesse/KV Hesse, 18.75% random sample of insurants from AOK Hesse, Germany) is used in the study. The study population is composed of 73?665 insurants >64?years of age continuously insured in the last quarter of 2009 and either continuously insured or deceased in 2010. Prevalence estimates are standardized to the population of Germany (31 December 2010). The variables age, sex, polypharmacy, hospital stay and nursing care are assessed for their independent association with general PIM prescription and among 11 therapeutic subgroups using multivariate logistic regression analysis.In 2010, 22.0% of the elderly received at least one PIM prescription (men: 18.3%, women: 24.8%). The highest PIM prevalence was observed for antidepressants (6.5%), antihypertensives (3.8%) and antiarrhythmic drugs (3.5%). Amitriptyline, tetrazepam, doxepin, acetyldigoxin, doxazosin and etoricoxib were the most frequently prescribed PIMs. Multivariate analyses indicate that women (OR 1.39; 95% CI: 1.34-1.44) and persons with extreme polypharmacy (≥10 vs. <5 drugs: OR 5.16; 95% CI: 4.87-5.47) were at higher risk for receiving a PRISCUS-PIM. Risk analysis for therapeutic groups shows divergent associations.PRISCUS-PIMs are widely used. Educational programs should focus on drugs with high treatment prevalence and call professionals' attention to those elderly patients who are at special risk for inappropriate medication. Copyright ? 2013 John Wiley & Sons, Ltd.
机译:这项研究的目的是评估德国最近公布的清单(PRISCUS)所表明的老年人中潜在不适当药物(PIM)的患病率,并评估与PIM处方相关的独立因素,包括治疗组的整体和单独因素。分析(健康保险样本AOK Hesse / KV Hesse,来自德国AOK黑森的18.75%的保险人随机样本)用于研究。该研究人群由73位665位年龄在64岁以上的保险人组成,这些人在2009年最后一个季度进行了连续保险,并在2010年进行了连续保险或去世。流行率估算是按德国人口的标准进行的(2010年12月31日)。使用多元Logistic回归分析评估了年龄,性别,多药店,住院时间和护理等变量与普通PIM处方以及11个治疗亚组之间的独立相关性.2010年,有22.0%的老年人至少接受了一种PIM处方(男性:18.3%,女性:24.8%)。抗抑郁药(6.5%),降压药(3.8%)和抗心律不齐药物(3.5%)的PIM患病率最高。阿米替林,四西tetra,多塞平,乙酰地高辛,多沙唑嗪和依托考昔是最常用的PIM。多因素分析表明,女性(OR 1.39; 95%CI:1.34-1.44)和极端多药人群(≥10vs. <5种药物:OR 5.16; 95%CI:4.87-5.47)接受PRISCUS的风险更高。 -PIM。治疗组的风险分析显示出不同的关联.PRISCUS-PIM被广泛使用。教育计划应集中于治疗率高的药物,并引起专业人员对那些有不适当药物治疗特别风险的老年患者的注意。版权? 2013 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号